Clinical Efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma
Top Cited Papers
- 1 May 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Glaucoma
- Vol. 27 (5), 445-449
- https://doi.org/10.1097/ijg.0000000000000934
Abstract
Purpose: To investigate the clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation (MP-CPC) in patients with refractory glaucoma. Materials and Methods: Retrospective case series of 79 consecutive patients who underwent MP-CPC at the Wills Eye Hospital from March 23, 2014 to June 23, 2016 and who had at least 3 months of follow-up. Treatment success was defined as an intraocular pressure (IOP) of 6 to 21 mm Hg or a reduction of IOP by 20%. Failure was defined as an inability to meet the criteria for success, need for retreatment >3 times, or need for incisional glaucoma surgery. Results: Patients had a mean follow-up time of 7.8±4.5 months. The mean IOP before MP-CPC was 31.9±10.2 mm Hg. The IOP was reduced by an average of 51% at the last follow-up and the mean number of IOP lowering medications was reduced from 2.3 at baseline to 1.5 at last follow-up. Treatment success rates were 75% at 3 months, 66% at 6 months, and 67% at last follow-up. Complications of MP-CPC included 7 patients with hypotony (8.8%), 21 patients with prolonged anterior chamber inflammation (1+ cell or flare for >3 mo, 26%), 13 patients with loss of ≥2 lines of best-corrected visual acuity at 3 months (17%), 4 patients with macular edema (5%), 2 patients with corneal edema and 2 patients with phthisis. Conclusions: MP-CPC is an effective treatment for patients with refractory glaucoma. Shorter treatment times with more frequent repeat treatments, if necessary, should be considered given the incidence of significant vision loss in this study.Keywords
This publication has 24 references indexed in Scilit:
- What's new in laser treatment for glaucoma?Current Opinion in Opthalmology, 2012
- Risk Factors for Hypotony After Transscleral Diode CyclophotocoagulationJournal of Glaucoma, 2012
- Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulationClinical & Experimental Ophthalmology, 2007
- Diode laser cycloablation in adult glaucoma: long‐term results of a standard protocol and review of current literatureClinical & Experimental Ophthalmology, 2006
- Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International WorkshopAmerican Journal of Ophthalmology, 2005
- Trans-scleral diode laser cyclophoto-coagulation in the treatment of diabetic neovascular glaucomaEye, 2004
- Cyclophotocoagulation A report by the american academy of ophthalmologyOphthalmology, 2001
- "Cyclodiode": results of a standard protocolBritish Journal of Ophthalmology, 1999
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- Mechanism of Intraocular Pressure Decrease after Contact Transscleral Continuous-Wave Nd:YAG Laser CyclophotocoagulationOphthalmic Research, 1994